Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Finnish Telestroke Pilot 2007-2009

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by Helsinki University Central Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Kuusankoski Regional Hospital Kuusankoski Finland
Kymenlaakso Central Hospital Kotka Finland
Tampere University Hospital Tampere Finland
Central Hospital of Lapland Rovaniemi Finland
South Carelia Central Hospital Lappeenranta Finland
Länsi-Pohja Central Hospital Kemi Finland
Information provided by:
Helsinki University Central Hospital
ClinicalTrials.gov Identifier:
NCT01136993
First received: June 3, 2010
Last updated: NA
Last verified: June 2010
History: No changes posted

June 3, 2010
June 3, 2010
May 2007
December 2010   (final data collection date for primary outcome measure)
The percentage of thrombolysis treatments per consultations [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
Safety (sICH) and Efficacy (mRS at 3 months) compared with on-site thrombolysis [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Finnish Telestroke Pilot 2007-2009
Finnish Telestroke Pilot 2007-2009

Objective is to describe two years experience from The Finnish Telestroke piloting between Helsinki University Central Hospital (HUCH), Department of Neurology, The Hub, and five hospitals, the spokes. The participating hospitals are from Rovaniemi (Lapland), Kemi (North-West of Finland), Lappeenranta, Kuusankoski and Kotka from South-East of Finland. All the participating hospitals have a stroke unit and the thrombolysis treatment and the follow up of the patients are carried in the treating hospital. The aim of the pilot is to provide these hospitals expertise in thrombolysis treatment during off-hours through teleconsultations.

The teleconsultations were begun between the participating hospitals 05/2007 after about 1 years preparation period. During the preparation period the staff from participating hospitals were trained with simulation training and lectures held by the local staff and the faculty of the Helsinki University hospital.

Telestroke consultation: During two way interactive audio-visual consultation the thrombolysis decision is based on: 1) the consultant going through a check up list of indications and no contraindications to the treatment together with the treating physician and 2) Clinical assessment of NIHSS by the treating physician under guidance of the consultant through the two way video system besides 3) Evaluation of the head CT scan.

The data registered is based on documents made at HUCH and the follow up data provided by the chief neurologist of the other hospitals. 109 teleconsultations have been documented over 2 years period. A unique feature of the Finnish pilot is the high percentage of consultations leading to thrombolysis treatment. Another special feature is that the consultant does the teleconsultation work besides other on call duties.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

All teleconsultations on stroke thrombolysis decision between the Hub (HUCH) and the 5 Spokes during 2 years time period.

Stroke
Not Provided
All bi-directional telestroke consultations
Tatlisumak T, Soinila S, Kaste M. Telestroke networking offers multiple benefits beyond thrombolysis. Cerebrovasc Dis. 2009;27 Suppl 4:21-7. Epub 2009 Jun 18. Review.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
109
December 2010
December 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • All stroke patients inside 4.5 hours from the symptom onset considered as thrombolysis candidates by the treating physician of the spoke. In suspected basilar artery thrombosis up to 48 h from symptom onset.

Exclusion Criteria:

  • Symptom onset > 4.5 h
Both
Not Provided
No
Contact: Tiina R Sairanen, MD, PhD tiina.sairanen@hus.fi
Contact: Turgut Tatlisumak, MD, PhD turgut.tatlisumak@hus.fi
Finland
 
NCT01136993
M1010NL0002
No
Dr. Tiina Sairanen, Department of Neurology, HUCH, Helsinki, Finland
Helsinki University Central Hospital
  • Kuusankoski Regional Hospital Kuusankoski Finland
  • Kymenlaakso Central Hospital Kotka Finland
  • Tampere University Hospital Tampere Finland
  • Central Hospital of Lapland Rovaniemi Finland
  • South Carelia Central Hospital Lappeenranta Finland
  • Länsi-Pohja Central Hospital Kemi Finland
Principal Investigator: Tiina Sairanen, MD, PhD Department of Neurology, HUCH, Helsinki, Finland
Helsinki University Central Hospital
June 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP